Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib and Radiotherapy in Elderly Esophageal Cancer
NCT01291823Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in esophageal cancer, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01291823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291823.